Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in ...

While millions obsess over LDL, top cardiologists reveal that a single "sticky" protein marker provides the most accurate ...

In this letter, we explore the mechanistic rationale behind sardine fasting and then move into the how-to: a practical, ...